Clinical Trials in Minneapolis

Showing 6941-6960 of 11,007 trials

Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia

NCT02171130

Up to two hundred (200) adult participants with type 1 diabetes (T1D) aged 18 to 75 years will be selected for inclusion in the study. The target is to obtain treatment response and user-experience data following use of nasal glucagon (AMG504-1) in treating episodes of hypoglycemia. The population will be enriched to include participants who suffer from impaired hypoglycemia awareness.

HypoglycemiaDiabetes MellitusDrug-Specific Antibodies

Eli Lilly and Company129 participantsStarted May 2014

Waltham, Massachusetts, United States • Minneapolis, Minnesota, United States • Albany, New York, United States +6 more locations

COMPLETEDNA< 1 mile

Stand & Move at Work

NCT02566317

A trial testing the efficacy of sit-stand workstations on decreasing sitting time and increasing light-intensity physical activity in samples of office worksites.

ObesityHypertensionDiabetes

Arizona State University630 participantsStarted Jan 2016

Tempe, Arizona, United States • Minneapolis, Minnesota, United States

COMPLETEDNA< 1 mile

Home-Based High Intensity Interval Training Intervention for Low Active Adults

NCT03479177

The purpose of this study is to examine the effect of a home-based high intensity interval training intervention on exercise among low active adults (defined as engaging in exercise 90 minutes or less per week). Participants will be randomly assigned to a HIIT-based intervention or a wait-list control each lasting 12 weeks (participants in the wait-list control condition will have the option of receiving the HIIT intervention following the 12 weeks).

Cardiovascular Diseases

University of Minnesota50 participantsStarted Jul 2018

Minneapolis, Minnesota, United States

Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia

Stand & Move at Work

Home-Based High Intensity Interval Training Intervention for Low Active Adults

Find Trials by Condition in Minneapolis

ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation

A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)

Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function

Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters

Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

Deuterated Phenanthrene Tetraol in Smokers Who Are at High Risk For Lung Cancer

Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma

A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.

Trial of IMO-8400 in Adult Patients With Dermatomyositis

Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris

Abbott Laboratories Alinity s Blood Screening Assays - Clinical Evaluation Protocol

A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)

THA Kinematics and Sound for Subjects Implanted Using Various Surgical Approaches

A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid Tumors

e-NOBORI Observational Registry of Nobori DES